Compare Merck & Co., Inc. (MRK) vs Upwork Inc (UPWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Upwork Inc — how do they compare? Merck & Co., Inc. trades at $148 (market cap $366.28B), while Upwork Inc trades at $8.24 (market cap $1.04B). The key difference: Merck & Co., Inc. is far larger — about 352.2× Upwork Inc's market cap, and Merck & Co., Inc. pays a 2.29% dividend while Upwork Inc pays none. Which is the better fit depends on your goals.
| MRK | UPWK | |
|---|---|---|
Market Cap | $366.28B | $1.04B |
Sector | Health | Industrials |
52-Week High | $156.43 | $22.11 |
52-Week Low | $77.60 | $7.84 |
Enterprise Value | $413.04B | $802.40M |
Dividend Yield | 2.29% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MRK trades at $148.49, down 1.23% on the day, with a bullish technical signal from moving averages and support near $147. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $2.22. Revenue reached $65.01B in 2025, and the acquisition of Terns Pharmaceuticals aims to bolster its oncology pipeline.
Outlook remains positive with a consensus price target of $157, offering ~6% upside. Risks include high P/E of 118.77 and competitive pressures in pharma. Institutional buying and a 67.57% buy rating from analysts support a constructive view, though net income margin of 4.77% warrants monitoring.
Upwork (UPWK) trades at $8.32, down 5.35% amid bearish technical signals and recent earnings volatility. The stock shows mixed fundamentals with strong gross margins of 77.21% but declining net income margins from 28.02% in 2024 to 14.65% in 2025. Recent Q2 2026 earnings beat expectations but weak guidance triggered a selloff. Analyst consensus remains positive with a $9.00 price target despite ongoing securities fraud investigations.
The stock presents a value opportunity with low P/E of 10.67 and P/S of 1.44, but faces significant headwinds from AI disruption to freelance demand and multiple legal investigations. Near-term performance depends on management's ability to navigate AI transition while maintaining client growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Upwork Inc
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with highly-skilled independent professionals. The develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to Clients.
Read more on UPWK →
